logo-loader
RNS
MicroSalt PLC

Result of General Meeting

RNS Number : 4757X
MicroSalt PLC
02 October 2026
 

MicroSalt Plc

("MicroSalt" or the "Company")

 

Result of General Meeting

 

MicroSalt (AIM: SALT), a leading manufacturer of full-flavour natural salt with approximately 50% less sodium, announces the results of its General Meeting (“GM”), held earlier today.

 

All six resolutions put to members were duly passed, with the number of votes cast for, against and withheld as follows:

 

 

For

Against

Votes Withheld

Total Votes Cast

 

Number of Votes

%

Number of Votes

%

Number of Votes

 

Ordinary Resolutions

1. To authorise the Directors to allot Ordinary Shares for cash in relation to the Fundraise up to an aggregate nominal amount of £10,400.00.

33,812,111

 

99.14%

 

294,741

 

0.86%

 

151,509

 

34,106,852

 

2. To authorise the Directors to allot Ordinary Shares for cash in connection with the exercise of convertible loan notes issued prior to the date of this resolution up to an aggregate nominal amount of £4,550.00.

33,898,226

 

99.39%

 

208,486

 

0.61%

 

151,649

 

34,106,712

 

3. To authorise the Directors to allot Ordinary Shares for cash up to an aggregate nominal amount of £23,918.41 (being approximately 20% of the Enlarged Share Capital).

33,812,617

 

99.14%

 

294,235

 

0.86%

 

151,509

 

34,106,852

 

Special Resolutions

4. Subject to the passing of Resolution 1, to authorise the Directors to disapply pre-emption rights granted to Shareholders pursuant to the Act, in respect of the allotment and issue of the Fundraising Shares.

33,893,531

 

99.37%

 

214,821

 

0.63%

 

150,009

 

34,108,352

 

5. Subject to the passing of Resolution 2, to authorise the Directors to disapply pre-emption rights granted to Shareholders pursuant to the Act, in respect of the allotment and issue of Ordinary Shares allotted and issued on connection with the exercise of convertible loan notes issued prior to the date of this resolution.

33,885,983

 

99.35%

 

222,369

 

0.65%

 

150,009

 

34,108,352

 

6. Subject to the passing of Resolution 3, to authorise the Directors to disapply pre-emption rights granted to Shareholders pursuant to the Act, in respect of the allotment and issue of Ordinary Shares up to an aggregate amount of £23,918.41 (being approximately 20% of the Enlarged Share Capital).

33,789,376

 

99.06%

 

318,976

 

0.94%

 

150,009

 

34,108,352

 

 

 

Enquiries:

 

MicroSalt plc

Via Gracechurch Group

Rick Guiney (CEO)

Gary Urmston, Interim CFO

 

 

 

Zeus (Nominated Adviser and Broker)

+44 (0)20 3829 5000

David Foreman / Ed Beddows (Investment Banking)

Nick Searle (Head of Equity Capital Markets)

 

 

 

Gracechurch Group (Financial PR)

+44 (0)20 4582 3500

Heather Armstrong, Alexis Gore, Rebecca Scott

 

 

 

About MicroSalt

 

MicroSalt is disrupting the global salt market with its patented, full-flavour, low-sodium salt designed for both food manufacturers and consumers. Using proprietary micron-sized particles, MicroSalt delivers the same salty taste as traditional salt with approximately 50% less sodium, offering a scalable solution to one of the world's most pressing health challenges.

Excess sodium consumption is a leading contributor to cardiovascular disease, the world's number one cause of death. The World Health Organisation has targeted a 30% reduction in global sodium intake by 2025, a shift projected to save seven million lives by 2030. The economic case is equally compelling: in the UK alone, cardiovascular disease costs £19 billion annually, and reducing average daily salt intake by just one gram could save over 4,000 lives and £288 million each year.

 

For more information, please visit www.microsaltinc.co or follow on X @microSaltPLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMUPGBAUUPQGWP
NO INVESTMENT ADVICE

Proactive Investors Australia Pty Ltd ACN 132 787 654 (the Company, we or us) provides you with access to the content set out above, including any news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) and this website (the Site) on the terms set out in this disclaimer, together with all other terms and conditions, disclaimers and other notices displayed elsewhere on this Site.

It is important for you to know that:

(a) none of the Content is, or is intended to be, general or personal advice

(b) the principal purpose of the Content is to provide factual information only and to comment on news;

(c) the Content does not contain or imply any recommendation or opinion intended to influence your financial decisions, including in respect of any particular security, portfolio of securities, transaction or investment strategy, and must not be relied upon by you as such;

(d) in providing you with the Content, we have not considered your objectives, financial situation or needs; and

(e) you should make your own enquiries and obtain your own independent advice prior to making any financial decisions.

The Content contains data (including but not limited to prices, statistics and calculated information) obtained from a variety of third party sources (Third Party Data). The Company does not make any representation or warranty that any of the Content, including the Third Party Data, will be reliable, accurate or complete. The Company disclaims all responsibility and liability arising in any way from any errors or omissions in the Content, including the Third Party Data, including any loss you may incur in connection with any action or decision made by you in reliance upon the Content or Third Party Data.

In certain circumstances the Company, its related bodies corporate, or their affiliates, may have received, or be entitled to receive, financial or other consideration in connection with providing information about certain entities on the Site, which may include the above Content.

FOR OUR FULL DISCLAIMER CLICK HERE

3 min read